The dollar amount is negligible relative to Natera's $54.6B market cap and all sales were pre-planned under 10b5-1 programs. No signal of deteriorating fundamentals or insider concern. Monitor next earnings for any guidance changes, but this cluster alone does not warrant action.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 5 $363.76entry
- T+1 · 6d ago −14.59%α −14.91% · $310.67
- T+4 · todayOpen
- T+5 · in 9h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Seven Natera insiders, including the CEO, Executive Chairman, CFO, and President of Clinical Diagnostics, sold a total of $3.96M in open-market sales over a 7-day window. All sales were under 10b5-1 plans, but the aggregate value represents approximately 0.007% of the $54.6B market cap, which is trivial relative to company size.
Key Financial Metrics
Key Facts
- Seven insiders sold shares in open-market transactions (Form 4 code S) totaling $3.96M
- All sales were conducted under 10b5-1 trading plans
- CEO Steven Chapman sold $1.46M, CFO Michael Brophy sold $811K, Executive Chairman Matthew Rabinowitz sold $698K
- Total sales represent about 0.007% of Natera's $54.6B market cap
- Sales occurred between October 26 and November 2, 2026
Financial Impact
Total insider sales of $3.96M, approximately 0.007% of market cap
Risk Factors
- Insider sales are routine and immaterial in size; no elevated risk identified
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NTRA-1793846143296 |
Track record
61 reports on NTRA
6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +6.55% at T+5 after the Oct 2, 2026 report. 6 of 9 went positive at some point.
Filters
- Nov 10, 20261d ago Insider Cluster Neutral 3/10 Entry $318.65 Now $311.98 −2.09% settles Nov 12
- Nov 6, 20265d ago SC 13G/A Neutral 3/10 Entry $310.67 to $320.39 Now $311.98 +0.42% ▲ +3.13% +0.76% vs SPY
- Nov 5, 20266d ago 8-K Mixed 6/10 Entry $310.67 to $320.39 Now $311.98 +0.42% ▲ +3.13% +0.76% vs SPY
- Nov 5, 20266d ago SC 13G Neutral 4/10 Entry $363.76 to $310.67 Now $311.98 −14.23% ▼ −14.59% −14.91% vs SPY
- Nov 4, 20266d ago Insider Cluster Neutral 2/10 Viewing Entry $363.76 to $310.67 Now $311.98 −14.23% ▼ −14.59% −14.91% vs SPY
- Nov 3, 20268d ago 144 Neutral 2/10 Entry $391.03 to $363.76 Now $311.98 −20.22% ▼ −6.97% −2.56% vs SPY
- Nov 2, 20269d ago 144 Neutral 2/10 Entry $388.63 to $391.03 Now $311.98 −19.72% ▲ +0.62% −1.03% vs SPY
- Nov 2, 20269d ago 144 Neutral 3/10 Entry $388.63 to $391.03 Now $311.98 −19.72% ▲ +0.62% −1.03% vs SPY
- Nov 2, 20269d ago 144 Neutral 1/10 Entry $388.63 to $391.03 Now $311.98 −19.72% ▲ +0.62% −1.03% vs SPY
- Nov 2, 20269d ago 144 Neutral 2/10 Entry $388.63 to $391.03 Now $311.98 −19.72% ▲ +0.62% −1.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers